COSM
Cosmos Health Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.27
+2.59%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.1x
Market Cap
$27.49M
MomentumView details →
1D Return
+2.59%
YTD Return
−46.39%
RSI (14)
63.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.1x
Market Cap
$27.49M
RSI (14)
63.3
MomentumView details →
1D Return
+2.59%
YTD Return
−46.39%
SummaryUpdated Jun 1, 2026
Cosmos Health Inc. (NASDAQ:COSM) is a vertically integrated pharmaceutical company founded in 2009 and headquartered in Chicago, Illinois. The company went public in July 2010 and operates as a specialty pharmaceutical manufacturer and distributor with a focus on branded and generic pharmaceuticals, nutraceuticals, and medical devices. Cosmos Health has established distribution operations across multiple countries, with key facilities in Greece and the United Kingdom, serving wholesale pharmaceutical distributors and independent retail pharmacies through both traditional distribution channels and e-commerce platforms.
Similar companies
Latest newsMore news →
Cosmos Health Inc. announced the launch of its Oliv18 nutraceutical product, a whole olive polyphenol formulation, with a staged rollout beginning with direct-to-consumer e-commerce and planned expansion into retail channels.11d agoCosmos Health Inc. reported Q2 2026 GAAP revenue of $18.99 million, up 28.8% year-over-year, with a net loss of $6.09 million and adjusted EBITDA of -$1.13 million.16d ago